HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Utility of tissue-specific transcription factors thyroid transcription factor 1 and Cdx2 in determining the primary site of metastatic adenocarcinomas to the brain.

AbstractCONTEXT:
Brain metastases of adenocarcinoma of unknown primary pose a diagnostic dilemma to the surgical pathologist. Although the most common source in these cases is the lung, determining a primary source is difficult on routinely stained slides. Immunohistochemical stain panels including differential cytokeratins, hormone receptors, and breast-specific proteins are commonly used in these cases. Recently, attention has turned to tissue-specific transcription factors, such as thyroid transcription factor 1 (TTF-1) and Cdx2, in the appraisal of metastatic adenocarcinomas.
OBJECTIVE:
To characterize the previously unpublished immunohistochemical expression of the relatively new tissue-specific transcription factor Cdx2 in metastatic adenocarcinomas to the brain.
DESIGN:
We reviewed the surgical pathology files of the H. Lee Moffitt Cancer Center and Research Institute, Tampa, Fla, and retrieved 38 consecutive cases of metastatic adenocarcinoma (22 pulmonary, 10 breast, 6 gastrointestinal [2 esophagus/gastroesophageal junction, 4 colorectal]) to the brain with confirmation of the primary site by chart review and histologic evaluation. Sections were immunohistochemically stained with antibodies to TTF-1, Cdx2, and cytokeratins 7 and 20 by standard methods.
RESULTS:
Specificities and positive predictive values for Cdx2 and TTF-1 equaled 100% for metastatic gastrointestinal and pulmonary adenocarcinomas, respectively. The negative predictive value of Cdx2 was also very high at 97%.
CONCLUSIONS:
Cdx2 is a specific and valuable tool for the surgical pathologist when faced with the common problem of metastatic adenocarcinoma of unknown primary. In conjunction with TTF-1, cytokeratin 7, and cytokeratin 20, Cdx2 can accurately differentiate the most common sources of metastatic adenocarcinoma to the brain.
AuthorsLeah B Strickland-Marmol, Andras Khoor, Sandra K Livingston, Amyn Rojiani
JournalArchives of pathology & laboratory medicine (Arch Pathol Lab Med) Vol. 131 Issue 11 Pg. 1686-90 (Nov 2007) ISSN: 1543-2165 [Electronic] United States
PMID17979487 (Publication Type: Evaluation Study, Journal Article)
Chemical References
  • CDX2 Transcription Factor
  • CDX2 protein, human
  • DNA-Binding Proteins
  • Homeodomain Proteins
  • Keratin-20
  • Keratin-7
  • TTF1 protein, human
  • Transcription Factors
Topics
  • Adenocarcinoma (secondary)
  • Brain Neoplasms (secondary)
  • Breast Neoplasms (diagnosis, metabolism, pathology)
  • CDX2 Transcription Factor
  • Colorectal Neoplasms (diagnosis, metabolism, pathology)
  • DNA-Binding Proteins (metabolism)
  • Diagnosis, Differential
  • Gastrointestinal Neoplasms (diagnosis, metabolism, pathology)
  • Homeodomain Proteins (metabolism)
  • Humans
  • Keratin-20 (metabolism)
  • Keratin-7 (metabolism)
  • Lung Neoplasms (diagnosis, metabolism, pathology)
  • Neoplasms, Unknown Primary (diagnosis, metabolism, pathology)
  • Predictive Value of Tests
  • Sensitivity and Specificity
  • Transcription Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: